BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17341537)

  • 1. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay.
    Oderda GM; Said Q; Evans RS; Stoddard GJ; Lloyd J; Jackson K; Rublee D; Samore MH
    Ann Pharmacother; 2007 Mar; 41(3):400-6. PubMed ID: 17341537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
    Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
    Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of opioid-related adverse events on outcomes in selected surgical patients.
    Oderda GM; Gan TJ; Johnson BH; Robinson SB
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):62-70. PubMed ID: 23302094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes.
    Kessler ER; Shah M; Gruschkus SK; Raju A
    Pharmacotherapy; 2013 Apr; 33(4):383-91. PubMed ID: 23553809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery.
    Pizzi LT; Toner R; Foley K; Thomson E; Chow W; Kim M; Couto J; Royo M; Viscusi E
    Pharmacotherapy; 2012 Jun; 32(6):502-14. PubMed ID: 22570188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
    Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
    JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adverse drug reactions on length of stay in surgical intensive care units.
    Vargas E; Terleira A; Hernando F; Perez E; Cordón C; Moreno A; Portolés A
    Crit Care Med; 2003 Mar; 31(3):694-8. PubMed ID: 12626971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery.
    Gillespie EL; White CM; Kluger J; Sahni J; Gallagher R; Coleman CI
    Clin Ther; 2005 Dec; 27(12):1963-9. PubMed ID: 16507383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized surveillance of adverse drug events in hospital patients.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    JAMA; 1991 Nov; 266(20):2847-51. PubMed ID: 1942452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the Effect of Intravenous Acetaminophen for Postoperative Pain Management on Length of Stay and Inpatient Hospital Costs.
    Shaffer EE; Pham A; Woldman RL; Spiegelman A; Strassels SA; Wan GJ; Zimmerman T
    Adv Ther; 2017 Jan; 33(12):2211-2228. PubMed ID: 27830448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of opioid-related adverse drug events in surgical patients.
    Oderda GM; Evans RS; Lloyd J; Lipman A; Chen C; Ashburn M; Burke J; Samore M
    J Pain Symptom Manage; 2003 Mar; 25(3):276-83. PubMed ID: 12614962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of adverse events of long-acting opioids in a state Medicaid program.
    Hartung DM; Middleton L; Haxby DG; Koder M; Ketchum KL; Chou R
    Ann Pharmacother; 2007 Jun; 41(6):921-8. PubMed ID: 17504834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug events in trauma patients.
    Lazarus HM; Fox J; Evans RS; Lloyd JF; Pombo DJ; Burke JP; Handrahan D; Egger MJ; Allen TL; Stevens MH
    J Trauma; 2003 Feb; 54(2):337-43. PubMed ID: 12579062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use.
    Webster BS; Verma SK; Gatchel RJ
    Spine (Phila Pa 1976); 2007 Sep; 32(19):2127-32. PubMed ID: 17762815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants.
    Zaidenstein R; Eyal S; Efrati S; Akivison L; Michowitz MK; Nagornov V; Golik A
    Pharmacoepidemiol Drug Saf; 2002; 11(3):235-8. PubMed ID: 12051123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of intravenous opioid dose on postoperative ileus.
    Barletta JF; Asgeirsson T; Senagore AJ
    Ann Pharmacother; 2011 Jul; 45(7-8):916-23. PubMed ID: 21730280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication reconciliation for reducing drug-discrepancy adverse events.
    Boockvar KS; Carlson LaCorte H; Giambanco V; Fridman B; Siu A
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):236-43. PubMed ID: 17062324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.